Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00058279 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Intraocular Melanoma
Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: ipilimumab

Sponsor

National Cancer Institute (NCI)